Exponential Biotherapies

About:

Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.

Description:

Exponential Biotherapies operates as a drug discovery and development company. It provides small molecule drugs to treat a range of severe inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections.

Total Funding Amount:

$10.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

The Hague, Zuid-Holland, The Netherlands

Founded Date:

1993-01-01

Contact Email:

elke.vanwachem(AT)expobio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2007-01-31

IPO Status:

Private

Industries: